Related Experiment Video
Updated: Mar 18, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Traditional Therapies for Severe Asthma
Eileen Wang1, Flavia C L Hoyte1
1Division of Allergy and Clinical Immunology, Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA; Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Colorado Hospital, 1635 Aurora Court, Aurora, CO 80045, USA.
Severe asthma, a complex respiratory condition, requires advanced treatment strategies. Understanding disease phenotypes and endotypes is key to developing targeted therapies for better outcomes.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Severe asthma is a heterogeneous respiratory disease impacting patients aged 6 and older.
- Current definitions involve high-dose inhaled corticosteroids and/or systemic corticosteroids to manage uncontrolled asthma.
- Existing treatment guidelines offer varying recommendations for severe asthma management.
Purpose of the Study:
- To review traditional therapies for severe asthma.
- To analyze the supporting data for these therapies.
- To discuss differing clinical recommendations.
Main Methods:
- Literature review of traditional severe asthma therapies.
- Analysis of clinical data and guideline recommendations.
- Exploration of emerging concepts in asthma endotypes and phenotypes.
Main Results:
- Traditional therapies for severe asthma are reviewed, with data supporting their use examined.
- Variations in treatment recommendations across guidelines are highlighted.
- The importance of understanding asthma heterogeneity is emphasized.
Conclusions:
- A deeper understanding of severe asthma endotypes and phenotypes is crucial.
- Targeted therapies hold promise for improving treatment efficacy and cost-effectiveness.
- Personalized medicine approaches are expected to enhance severe asthma management outcomes.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

